Clinical Trial Update: Capecitabine With Digoxin for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating capecitabine with digoxin for metastatic breast cancer; study terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DIGOXIN (Digoxin)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-11-08